安徽研发新冠疫苗是真的吗 安徽研发新冠疫苗效果如何-看世界

安徽研发新冠疫苗是真的吗 安徽研发新冠疫苗效果如何

 据媒体报道,2月20日上午,安徽省新型冠状病毒肺炎疫情防控工作领导小组办公室举行的防疫发展“两手抓”复工复产“四带头”新闻发布会上,安徽飞龙科马生物制药有限公司总经理蒲江介绍,目前疫苗正处于临床前研究阶段,预计6月份可以进入临床试验。

Novel coronavirus pneumonia prevention and control work leading group office in Anhui province held the "four leading" resumption of production and "resumption of production" in the forenoon of February 20th. According to media reports, Pujiang, the general manager of Anhui Zhi Fei Long Ma Biological Pharmaceutical Co., Ltd., is currently in pre clinical research stage, and is expected to enter clinical trials in June.

据了解,目前国内外科研机构分别采用灭活疫苗、亚单位疫苗、病毒载体疫苗、核酸疫苗等不同技术路径开发新型冠状病毒疫苗,而智飞龙科马研发的亚单位疫苗则具有众多优势:

It is understood that novel coronavirus vaccines are developed by different domestic and foreign scientific research institutions, including inactivated vaccine, subunit vaccine, viral vector vaccine, nucleic acid vaccine and so on.

(1)无核酸成分,其安全性更高,稳定性更好;

(1) Without nucleic acid, it has higher security and better stability;

(2)免疫原性强、免疫持久,不仅可以产生体液免疫应答,还可以诱导细胞免疫;

(2) With strong immunogenicity and lasting immunity, it can not only produce humoral immune response, but also induce cellular immunity;

(3)借助工程细胞表达系统,可快速实现规模化生产。

(3) With the help of engineering cell expression system, large-scale production can be realized quickly.

春节假期以来,智飞龙科马的研发人员一直加班加点,目前他们研发的新冠疫苗已经完成了疫苗抗原序列的设计及表达载体构建,正在开展工程细胞株筛选工作,同时已制备了一批抗原蛋白,正在进行疫苗有效性验证。 

Since the Spring Festival holiday, the R & D personnel of zhifeilongcoma have been working overtime. At present, the new crown vaccine they developed has completed the design of vaccine antigen sequence and the construction of expression vector. They are carrying out the work of engineering cell line screening. At the same time, they have prepared a batch of antigen proteins and are carrying out the validation of vaccine effectiveness.  

蒲江表示,按照目前进展,公司研制的新馆病毒疫苗预计可以在今年6月申请临床试验。“新冠病毒疫苗是创新性疫苗,要充分评估疫苗的风险。我们将全力以赴,克服困难,在确保疫苗安全有效的前提下,力争疫苗尽早获批上市。”

Pujiang said that according to the current progress, the company's new library virus vaccine is expected to apply for clinical trials in June this year. "The new coronavirus vaccine is an innovative vaccine, and the risk of the vaccine should be fully evaluated. We will spare no effort to overcome difficulties and strive to get the vaccine approved for market as soon as possible on the premise of ensuring the safety and effectiveness of the vaccine. "

声明:转载此文是出于传递更多信息之目的。若有来源标注错误或侵犯了您的合法权益,请作者持权属证明与本网联系,我们将及时更正、删除,谢谢。

Disclaimer: This article is reproduced for the purpose of transmitting more information. If there is a source marking error or infringing your legitimate rights and interests, please contact our website with the ownership certificate. We will correct and delete it in time. Thank you.

免责声明:文章来自互联网,不代表本站的观点,如有侵权或不实言论,请第一时间联系删除,谢谢!!

本文由 看世界 作者:小小 发表,其版权均为 看世界 所有,文章内容系作者个人观点,不代表 看世界 对观点赞同或支持。如需转载,请注明文章来源。

发表评论